Changing Minds Protocol

Treatment offers ray of hope

Down syndrome protocol ignites debate on use

Michael Schroeder

The Journal Gazette

One day recently, Jordan Blevins’ sister, Sarah, caught him doing a newspaper crossword puzzle.

”I was just amazed,“ said Sarah, 19, who doesn’t get to see her brother much between work and school – she’s a sophomore at Indiana University-Purdue University Fort Wayne. Still, in the limited time they spend together, she’s noticed marked changes in his spelling and sociability: ”He’ll take to people (where) he used to kind of hide and shy away.“

Jordan, 16, had been on the lower functioning end for children with Down syndrome, but now he’s approaching the other end of the spectrum, says his mother, Linda Blevins. She owes that to an experimental protocol developed by a Houston-based woman and parent of a child with Down syndrome.

 

Doctor's Reference Guide

Changing the Minds of Children and Adults with Down syndrome

The Changing Minds Foundation in conjunction with Dr. Garner at Stanford University has developed an exciting protocol that enhances cognitive ability in children and adults with Down syndrome.

   

Protocol

Ginkgo Biloba

Ginkgo Biloba -  In 2004, Stanford University discovered the main culprit, GABA receptor, an inhibitor, was ON continuously in individuals with Down syndrome. (Supporting Study) The result was- it did not allow the nerves in the memory and learning area of the brain to fire. In other words, the nerves were shut down.  To balance the GABA receptor, a GABA antagonist was used to turn it down. (Supporting Study) Ginkgo Biloba is a GABA antagonist which has been used for over 4000 years (Supporting Study).

   

Teresa Cody

Teresa Cody and son Neal

Teresa Cody, Founder of the Changing Minds Protocol, with son Neal

Read more about Teresa Cody